Malaria drug fails to prevent COVID-19 in a rigorous study

A malaria drug President Donald Trump took to try to prevent COVID-19 proved ineffective for that in the first large, high-quality study to test it in people in close contact with someone with the disease.

Indirect effects of the COVID-19 pandemic on malaria intervention coverage, morbidity, and mortality in Africa: a geospatial modelling analysis - The Lancet Infectious Diseases

Malaria drug fails to prevent COVID-19 in a rigorous study - Aruba Today

Chloroquine for COVID-19: rationale, facts, hopes, Critical Care

Coronavirus: Why Trump is at odds with experts over using malaria drugs

In-line treatments and clinical initiatives to fight against COVID-19 outbreak - ScienceDirect

The 'very, very bad look' of remdesivir, the first FDA-approved COVID-19 drug, Science

Frontiers Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19

Malaria drug fails to prevent COVID-19 in a rigorous study (Update)

Severe Covid-19

Chloroquine's use to treat COVID-19 is backed by US government, but many questions remain

FDA Warns Against Use of Chloroquine Outside of Clinical Trials - WSJ

Malaria drug fails to prevent coronavirus in rigorous study - Los Angeles Times

New studies clarify what drugs help, hurt for COVID-19